FDA End-of-Phase 2 meeting scheduled to take place in the first quarter of 2026 for the chronic cough program in patients with idiopathic pulmonary fibrosis Phase 2b refractory chronic cough trial...

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that Ameet Mallik, Chief Executive Officer, will...

Karsan, the world's technology-driven mobility brand in next-generation public transport, made a strong appearance at CES 2026, one of the technology world's leading trade shows. The brand, which...

After nearly two years in stealth, Willo Technologies Oy ("Willo"), a European deep-tech company, today announced its public launch, unveiling a working system that demonstrates wireless power...

CN Energy Group. Inc. (NASDAQ: CNEY) ("CNEY" or the "Company"), a Nasdaq-listed company, today announced that its wholly-owned subsidiary, Pathenbot Group Inc. ("Pathenbot"), has received the...